How much funding has Oncoliq raised?

Oncoliq has raised $2.8M in total funding, most recently a Seed round.

Who are Oncoliq's investors?

Oncoliq's investors include AIR Capital, Draper University.

Where is Oncoliq headquartered?

Oncoliq is headquartered in Buenos Aires, Argentina.

What industry is Oncoliq in?

Oncoliq operates in Biotech, Healthcare.

Oncoliq

When cancer is detected early

Buenos Aires, Argentina · $2.8M raised

Biotech

Healthcare

Headquarters: Buenos Aires
Employees: 1–10
Business Model: B2B
Website: oncoliq.bio

Total Funding: $2.8M
Last Round: $2.8M SeedDec 2024
Rounds: 1

About

Oncoliq is an Argentine biotech startup developing a multi-cancer early detection platform using liquid biopsy technology. The company's approach isolates and analyzes microRNAs from a small blood sample to screen for multiple cancer types simultaneously, with a focus on reducing cancer mortality through accessible, scalable screening. Co-founded by scientists Marina Simian (CEO) and Adriana De Siervi (CSO), Oncoliq is currently conducting clinical trials in partnership with leading Argentine hospitals and research institutions, and raised $2.84M in a seed round in 2025.

Summary

Oncoliq is a Biotech company based in Buenos Aires, Argentina. It has raised $2.8M in total across 1 round, most recently a $2.8M Seed round in Dec 2024. Investors include AIR Capital and Draper University.

LinkedIn X (Twitter)